Sodium butyrate induces apoptosis enhanced by JAK2 inhibitor Fedratinib in NK/T-cell lymphoma cell

Key Points

• Apoptosis is significantly induced in NK/T-cell lymphoma cells when treated with sodium butyrate and Fedratinib.
• The combined treatment results in a notable increase in cell death compared to either treatment alone.
• Analysis of the treatment effects indicates a potential new therapeutic strategy against NK/T-cell lymphomas.
• This work suggests a promising direction for future investigations and clinical applications in cancer treatment.